NS2B‐NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review-Reference-Cited by-同舟云学术

NS2B‐NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review

Published:2021-10-20 Issue:2 Volume:94 Page:442-453
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Nunes Damiana Antônia de Fátima¹,Santos Felipe Rocha da Silva¹,Fonseca Sara Thamires Dias¹,Lima William Gustavo¹,Nizer Waleska Stephanie da Cruz²,Ferreira Jaqueline Maria Siqueira¹,Magalhães José Carlos³^ORCID

Affiliation:

1. Department of Health Sciences, Laboratory of Medical Microbiology, Campus Centro Oeste Dona Lindu Universidade Federal de São João del‐Rei Divinópolis Minas Gerais Brasil

2. Department of Health Sciences Carleton University Ottawa Ontario Canada

3. Laboratory of Virology and Cellular Technology, Department of Chemistry, Biotechnology, and Bioprocess Engineering Universidade Federal de São João del‐Rei Ouro Branco Minas Gerais Brasil

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27386

Reference82 articles.

1. A review on Zika virus outbreak, epidemiology, transmission and infection dynamics